Transgenomic Company Profile (NASDAQ:TBIO)

About Transgenomic

Transgenomic logoTransgenomic, Inc. is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment. The Company is engaged in the provision of its Multiplexed ICE COLD-PCR (MX-ICP) product to the clinical market, enabling the use of blood and other bodily fluids for diagnosis, monitoring and treatment of cancer. MX-ICP amplifies the ability to detect genetic mutations by approximately 100 to 400 fold. MX-ICP is validated internally on sequencing platforms, including Sanger, Next Gen Sequencing and Digital polymerase chain reaction (PCR). Its laboratory in Omaha, Nebraska is focused on providing genetic analytical services related to oncology and pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical and biotechnology companies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Scientific & Technical Instruments
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TBIO
  • CUSIP:
Key Metrics:
  • Previous Close: $0.68
  • 50 Day Moving Average: $0.6391
  • 200 Day Moving Average: $0.3618
  • 52-Week Range: $0.15 - $1.59
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.32
  • P/E Growth: 0.0000
  • Market Cap: $16.86M
  • Outstanding Shares: 24,786,000
  • Beta: 0.45
Profitability:
  • Net Margins: -1,932.70%
  • Return on Assets: -267.85%
Debt:
  • Current Ratio: 0.05%
  • Quick Ratio: 0.05%
Additional Links:
Companies Related to Transgenomic:

Analyst Ratings

Consensus Ratings for Transgenomic (NASDAQ:TBIO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Transgenomic (NASDAQ:TBIO)
Show:
DateFirmActionRatingPrice TargetDetails
8/14/2015Craig HallumLower Price TargetBuy$8.00View Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Transgenomic (NASDAQ:TBIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/11/2016        
8/12/2016Q216($0.10)ViewListenView Earnings Details
5/24/2016Q116($0.10)ViewListenView Earnings Details
11/12/2015Q315($0.27)($0.18)$6.65 million$4.00 millionViewListenView Earnings Details
8/13/2015Q215($0.41)($0.30)$7.10 million$7.00 millionViewListenView Earnings Details
5/14/2015Q115($0.52)($0.36)$6.80 million$6.51 millionViewListenView Earnings Details
4/15/2015Q414($0.56)($0.77)$6.20 million$7.70 millionViewN/AView Earnings Details
10/30/2014($0.58)($0.61)ViewN/AView Earnings Details
5/7/2014($0.47)($0.60)ViewN/AView Earnings Details
3/12/2014($0.36)($0.05)ViewN/AView Earnings Details
8/6/20132Q13($0.03)($0.03)ViewN/AView Earnings Details
5/8/20131Q13($0.03)($0.04)ViewN/AView Earnings Details
3/13/20134Q12($0.03)($0.03)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Transgenomic (NASDAQ:TBIO)
Current Year EPS Consensus Estimate: $-1.4500 EPS
Next Year EPS Consensus Estimate: $-2.1400 EPS

Dividends

Dividend History for Transgenomic (NASDAQ:TBIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Transgenomic (NASDAQ:TBIO)
Insider Ownership Percentage: 1.90%
Institutional Ownership Percentage: 34.84%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/22/2014Leroy C KoppMajor ShareholderSell413,050$3.70$1,528,285.00View SEC Filing  
10/2/2013Leroy C KoppMajor ShareholderBuy9,000$0.39$3,510.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Transgenomic (NASDAQ:TBIO)
DateHeadline
News IconTechnical Trading: Focus on Shares of Transgenomic Inc. (TBIO) - Rives Journal (NASDAQ:TBIO)
rivesjournal.com - February 13 at 8:38 PM
prnewswire.com logoSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Transgenomic, Inc. - TBIO - PR Newswire (press release) (NASDAQ:TBIO)
www.prnewswire.com - February 13 at 8:38 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Transgenomic, Inc. - TBIO (NASDAQ:TBIO)
finance.yahoo.com - February 13 at 8:38 PM
News Icon2 Movers to Watch for Transgenomic Inc (NASDAQ:TBIO), Fossil Group Inc (NASDAQ:FOSL) - Financial Breaking News (NASDAQ:TBIO)
wsbreakingnews.com - February 11 at 8:15 PM
News IconRSI Watch: Transgenomic Inc. (NASDAQ:TBIO) - The Oracle Examiner (NASDAQ:TBIO)
oracleexaminer.com - February 7 at 1:17 AM
istreetwire.com logoStocks To Track: EXCO Resources, Inc. (XCO), Transgenomic, Inc ... - iStreetWire (NASDAQ:TBIO)
istreetwire.com - February 7 at 1:17 AM
News IconThe Way Analysts See Transgenomic, Inc. (NASDAQ:TBIO) - Post Analyst (NASDAQ:TBIO)
postanalyst.com - February 6 at 8:04 AM
News IconCan This Stock Grab Upward Traction: Transgenomic, Inc. (NASDAQ:TBIO) - Prospect Journal (NASDAQ:TBIO)
prospectjournal.com - February 1 at 6:48 AM
News IconTransgenomic Inc TBIO Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:TBIO)
www.bioportfolio.com - January 29 at 10:33 PM
News IconThe Interpublic Group of Companies, Inc. (NYSE:IPG) shows optimistic Trends (NASDAQ:TBIO)
larampadinapoli.com - January 28 at 6:52 AM
News IconWorth Watching Stocks: Transgenomic Inc. (NASDAQ:TBIO), Citizens Financial Group, Inc. (NYSE:CFG) - The Newburgh Press (NASDAQ:TBIO)
newburghpress.com - January 23 at 11:12 PM
News IconTransgenomic, Inc. (TBIO) Stock Price Decreases -12.25% - Highland Mirror (NASDAQ:TBIO)
www.highlandmirror.com - January 23 at 8:11 AM
News IconDigging Up the Facts on Dick's Sporting Goods, Inc. (DKS) (NASDAQ:TBIO)
diy-home-garden.com - January 21 at 3:03 AM
4-traders.com logoTRANSGENOMIC INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K) (NASDAQ:TBIO)
www.4-traders.com - January 20 at 7:00 AM
biz.yahoo.com logoTRANSGENOMIC INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (NASDAQ:TBIO)
biz.yahoo.com - January 20 at 7:00 AM
News IconTransgenomic, Inc. (NASDAQ:TBIO) Analytical Analysis - The Newburgh Press (NASDAQ:TBIO)
newburghpress.com - January 19 at 3:31 AM
News IconAre Institutions Trimming Down Their Positions In Transgenomic, Inc. (NASDAQ:TBIO) - Wall Street Beacon (NASDAQ:TBIO)
wsbeacon.com - January 19 at 3:31 AM
biz.yahoo.com logoTRANSGENOMIC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Triggering Events That Accelerate or (NASDAQ:TBIO)
biz.yahoo.com - January 17 at 11:10 PM
News IconNews Roundup: Transgenomic Inc. (NASDAQ:TBIO), AK Steel Holding Corporation (NYSE:AKS) - The Newburgh Press (NASDAQ:TBIO)
newburghpress.com - January 15 at 7:37 PM
News IconMarkets End Mostly Higher, How Did This Stock Fare: Transgenomic ... - Wall Street Beacon (NASDAQ:TBIO)
wsbeacon.com - January 15 at 7:37 PM
News IconGame of the Year: Nintendo On (NASDAQ:TBIO)
seputarkita.info - January 14 at 6:30 AM
News IconTransgenomic Inc (NASDAQ:TBIO) Is This Weeks Big Biotech Runner (NASDAQ:TBIO)
www.insiderfinancial.com - January 14 at 6:30 AM
feeds.benzinga.com logoTransgemonic Up Another 33% Following Yesterday's 295% Run (NASDAQ:TBIO)
feeds.benzinga.com - January 13 at 10:17 AM
baystreet.ca logoTransgenomic Inc. Announces Collaboration With LifeLabs, Shares Skyrocket 233% On News (NASDAQ:TBIO)
www.baystreet.ca - January 12 at 11:48 PM
streetinsider.com logoTransgenomic (TBIO) Says LifeLabs Selects ICE COLD-PCR as Its Mutation Enrichment Platform (NASDAQ:TBIO)
www.streetinsider.com - January 12 at 11:48 PM
News IconTransgenomic (TBIO), LifeLabs Ink Mutation Enrichment Technology Deal (NASDAQ:TBIO)
galaxystocks.com - January 12 at 11:48 PM
rttnews.com logoTransgenomic Inc. (TBIO) Has Jumped To A 9-Month High (NASDAQ:TBIO)
www.rttnews.com - January 12 at 11:48 PM
finance.yahoo.com logoTransgenomic Announces Leading Clinical Laboratory Services Provider LifeLabs Selects ICE COLD-PCR as Its Mutation Enrichment Platform (NASDAQ:TBIO)
finance.yahoo.com - January 12 at 11:48 PM
finance.yahoo.com logo7:31 am Transgenomic announces Lifelabs selected its ICE COLD-PCR technology as its mutation enrichment platform for cancer testing; separately announces issuance of a new Canadian patent for ICP (NASDAQ:TBIO)
finance.yahoo.com - January 12 at 11:48 PM
News IconMarket Focus: Watching Shares of Transgenomic, Inc. (NASDAQ:TBIO) - Wall Street Beacon (NASDAQ:TBIO)
wsbeacon.com - January 8 at 2:30 AM
News IconPeering into Recent Action from Transgenomic, Inc. (NASDAQ:TBIO) - Prospect Journal (NASDAQ:TBIO)
prospectjournal.com - January 7 at 5:53 AM
biz.yahoo.com logoTRANSGENOMIC INC Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Obligation or a (NASDAQ:TBIO)
biz.yahoo.com - January 7 at 5:53 AM
News IconChecking ROIC Numbers for Transgenomic, Inc. (NASDAQ:TBIO) - Wall Street Beacon (NASDAQ:TBIO)
wsbeacon.com - January 6 at 6:02 AM
News IconCheap Stock Alert on Transgenomic, Inc. (NASDAQ:TBIO) - Prospect Journal (NASDAQ:TBIO)
prospectjournal.com - January 4 at 5:57 AM
News IconABC stores to be open on New Year's Day for first time (NASDAQ:TBIO)
seputarkita.info - January 2 at 7:52 PM
News IconFuneral Being Held for Teen Killed in Cape Cod Crash (NASDAQ:TBIO)
seputarkita.info - January 1 at 11:16 PM
wallstrt24.com logoTraders Alert Huntington Bancshares Incorporated (NASDAQ:HBAN), Transgenomic Inc (NASDAQ:TBIO) - Wall Street 24 (NASDAQ:TBIO)
wallstrt24.com - January 1 at 8:09 AM
News IconBlowing snow, slippery roads: What to expect today when driving in CNY (NASDAQ:TBIO)
seputarkita.info - December 31 at 7:52 PM
News IconRipe for A Big Move? Update on Transgenomic, Inc. (NASDAQ:TBIO) - Prospect Journal (NASDAQ:TBIO)
prospectjournal.com - December 30 at 10:35 PM
News IconCheap Stock Alert & Update on Transgenomic, Inc. (NASDAQ:TBIO) - Prospect Journal (NASDAQ:TBIO)
prospectjournal.com - December 24 at 1:19 AM
News IconPrimed for Breakout or Bust? A look at Transgenomic, Inc. (NASDAQ:TBIO) - Prospect Journal (NASDAQ:TBIO)
prospectjournal.com - December 21 at 1:22 AM
News IconWatching Stock Levels for Transgenomic, Inc. (NASDAQ:TBIO) - Wall Street Beacon (NASDAQ:TBIO)
wsbeacon.com - December 20 at 8:21 PM
News IconCompany Watch: Focusing on Shares of Transgenomic, Inc. (NASDAQ:TBIO) - Wall Street Beacon (NASDAQ:TBIO)
wsbeacon.com - December 18 at 2:39 AM
News IconTransgenomic, Inc. (NASDAQ:TBIO) Insider Trading Update - The Newburgh Press (NASDAQ:TBIO)
newburghpress.com - December 14 at 3:18 PM
News IconWatching the Levels for Transgenomic, Inc. (NASDAQ:TBIO) - Wall Street Beacon (NASDAQ:TBIO)
wsbeacon.com - December 14 at 3:18 PM
wallstrt24.com logoNotable Movers Edwards Lifesciences Corp (NYSE:EW ... - Wall Street 24 (NASDAQ:TBIO)
wallstrt24.com - December 13 at 1:17 AM
News IconShares in View: Transgenomic, Inc. (NASDAQ:TBIO) - Wall Street Beacon (NASDAQ:TBIO)
wsbeacon.com - December 13 at 1:17 AM
News IconTrending Stocks in Review: Transgenomic Inc. (NASDAQ:TBIO), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) - The Newburgh Press (NASDAQ:TBIO)
newburghpress.com - December 11 at 7:03 PM
News IconROIC Watch for Transgenomic, Inc. (NASDAQ:TBIO) - Business Daily Leader (NASDAQ:TBIO)
businessdailyleader.com - December 7 at 12:47 AM
News IconReady for an Upsurge? Analysts Chime in on Transgenomic, Inc. (NASDAQ:TBIO) - Prospect Journal (NASDAQ:TBIO)
prospectjournal.com - December 6 at 8:15 AM

Social

What is Transgenomic's stock symbol?

Transgenomic trades on the NASDAQ under the ticker symbol "TBIO."

When will Transgenomic announce their earnings?

Transgenomic is scheduled to release their next quarterly earnings announcement on Friday, November, 11th 2016.

Who owns Transgenomic stock?

Transgenomic's stock is owned by many different of institutional and retail investors. Top institutional investors include Third Security LLC (30.46%) and Renaissance Technologies LLC (1.55%).

Who bought Transgenomic stock? Who is buying Transgenomic stock?

Transgenomic's stock was bought by a variety of institutional investors in the last quarter, including Third Security LLC and Renaissance Technologies LLC.

How do I buy Transgenomic stock?

Shares of Transgenomic can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Transgenomic stock cost?

One share of Transgenomic stock can currently be purchased for approximately $0.68.

Transgenomic (NASDAQ:TBIO) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Transgenomic (NASDAQ:TBIO)

Earnings History Chart

Earnings by Quarter for Transgenomic (NASDAQ:TBIO)

Dividend History Chart

Dividend Payments by Quarter for Transgenomic (NASDAQ:TBIO)

Last Updated on 2/21/2017 by MarketBeat.com Staff